United States Cytomegalovirus (CMV) Infection Market Insights, Epidemiology and Market Forecasts 2016-2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast - 2023 -United States" drug pipelines to their offering.

The US market size of Cytomegalovirus (CMV) infection shall reach to USD 609.88 Million by the end of 2023. The market size for Prophylaxis is expected to grow at a CAGR of 3.71% from 2013-2023, while the sales for the therapeutic shall increase at a CAGR of 3.55% from the year 2013-2023. As per estimation, the US Prophylaxis market is relatively higher than the therapeutic market.

United States Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast 2023 provides an overview of the disease and market size of the CMV for United States. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.

As per estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023.

Key Topics Covered:

  1. Cytomegalovirus Infections
  2. Disease Overview
  3. Symptoms of cytomegalovirus (CMV) Infection
  4. Etiology
  5. Risk Factors
  6. Pathogenesis of human cytomegalovirus
  7. Pathophysiology of cytomegalovirus infection
  8. Diagnosis
  9. Treatment Algorithm for Cytomegalovirus Infections
  10. Treatment for Congenital CMV Infection
  11. Treatment of Ganciclovir resistant CMV
  12. Treatment Guidelines
  13. Recommendations for Treating Cytomegalovirus Infections
  14. Disease Management
  15. Epidemiology and Patient Population
  16. United States
  17. Assumptions and Rationale
  18. Total CMV Prevalent, Diagnosed and Treatable Cases
  19. CMV Patients among Transplants
  20. Infant Patients at High Risk of CMV
  21. HIV Patients at High Risk of CMV in United States
  22. Unmet Medical Needs
  23. Marketed Products

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/wr8tt4/cytomegalovirus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs